Preclinical characterization of DK-AT390HCl, a potent PIKfyve inhibitor in colorectal cancer models

Biomedicine & Pharmacotherapy · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles